Mesalamine Capsule, Extended Release
Product Images NDC 51407-976

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 51407-976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-976-12ol (Mesalamine ER Capsules USP 0.375g)

51407-976-12ol (Mesalamine ER Capsules USP 0.375g)
Label for Mesalamine extended-release capsules USP 0.375 g by Golden State Medical Supply, Inc. The label includes the NDC 51407-976-12, a blue box showing the strength 0.375 g, and a quantity of 120 capsules. It also provides storage instructions, child-resistant packaging information, and marketing details with GSMS Incorporated in Camarillo, California.*
FDA Label Image

Image (Mesalamine 01)

Image (Mesalamine 01)
Mesalamine 0.375 g extended-release capsules packaging label from Golden State Medical Supply, Inc. The label displays the product name Mesalamine with the strength of 0.375 grams for oral administration. The packaging shows the capsules inside a blister pack, with the label indicating prescription drug status and manufacturer details. The product NDC 51407-976 is visible.*
FDA Label Image

Chemical Structure (Mesalamine 02)

Chemical Structure (Mesalamine 02)
Chemical structure of Mesalamine, showing a benzene ring with two hydroxyl groups, one amino group, and a carboxylic acid group attached.*
FDA Label Image

Image (Mesalamine 03)

Image (Mesalamine 03)
Mesalamine 0.375 g extended release capsules in a clear plastic blister pack with ten capsules arranged in two rows of five. The label shows the Golden State Medical Supply, Inc. name and product NDC 51407-976, indicating the oral dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.